Stocktoria
Anteris Technologies Global Corp. AVR
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2024-12-13
Anteris Technologies Global Corp. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.9M | $2.7M |
| R&D expense | $69.1M | $51.5M |
| SG&A expense | $26.1M | $28.2M |
| Operating income | -$93.9M | -$78.4M |
| Income tax | $0 | $0 |
| Net income | -$94.1M | -$76.3M |
| EPS (diluted) | $-2.55 | $-3.68 |
| Operating cash flow | -$77.8M | -$61.2M |
| Free cash flow | -$79.8M | -$63.5M |
| Cash & equivalents | $6.7M | $70.5M |
| Inventory | $152,000 | $513,000 |
| Total assets | $23.0M | $80.7M |
| Total liabilities | $23.2M | $18.0M |
| Shareholders' equity | -$253,000 | $62.8M |
Growth · year-over-year · Revenue CAGR -29.2%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | -29.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.